Vector Events: BioTrinity 2009 Sees Record Registrations - Four Weeks to Register

Wed, 04 Mar 2009 13:48:00 GMT

<TABLE style="PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; WIDTH: 100%; PADDING-TOP: 0px; HEIGHT: 100%; BACKGROUND-COLOR: #020a27"> <TBODY> <TR> <TD align=middle colSpan=2 height=25> <DIV align=center><A href="http://www.biotrinity.com/2009/fourweeks.htm" target=_blank>View this message in a browser</A></DIV></TD></TR> <TR> <TD bgColor=#020a27> <TABLE cellSpacing=0 cellPadding=0 width=600 align=center bgColor=#ffffff border=0> <TBODY> <TR> <TD bgColor=#020a27><A href="http://www.biotrinity.com" target=_blank></A> </TD></TR> <TR> <TD> <DIV align=center><A href="http://www.biotrinity.com/registration.html"><IMG alt="BioTrinity logo" src="http://biotrinity.com/images/email_logo1.gif" border=0> </A></DIV></TD></TR> <TR> <TD style="PADDING-LEFT: 5px; PADDING-BOTTOM: 10px" vAlign=top rowSpan=2>  <DIV align=center><IMG alt=" " src="http://biotrinity.com/images/negative_photo_strip1.jpg" border=0></DIV> Record Registrations for BioTrinity 2009 (April 2-3) UK's Premier Biotechnology and Investment Conference <DIV align=center><A href="http://www.partneringone.com/registration.php?id=5444f$b7CO2D0GXZGAw&regtype=12444f$b75XWW8TPtGCA" target=_blank>Click here to register</A></DIV> Dear Vector Events Subscriber, Registrations for BioTrinity 2009 have surged in recent weeks, and we're delighted to announce record registration levels are 50% higher than last year.  With four weeks to go, the UK's Premier Biotech and Investment Conference boasts the participation of over thirty <A href="http://www.biotrinity.com/investors.html">VCs and investors</A> with over $33bn under management among more than 240 companies confirmed as participating.  60% of the top 20 <A href="http://www.biotrinity.com/pharma.html">global pharma</A> now have senior licensing presence confirmed including AstraZeneca, Roche, Novartis, Eli Lilly and GSK. Five key facts about BioTrinity 2009 - Oxford <TABLE> <TBODY> <TR> <TD width=100></TD> <TD> <IMG alt=" " src="http://www.biotrinity.com/images/tri.gif">12 of world's top 20 global pharma represented <IMG alt=" " src="http://www.biotrinity.com/images/tri.gif">240 <A href="http://www.biotrinity.com/companies_attending.html">companies</A> already confirmed from 14 countries <IMG alt=" " src="http://www.biotrinity.com/images/tri.gif">Partnering is live and uniquely takes place in private rooms <IMG alt=" " src="http://www.biotrinity.com/images/tri.gif">Gala Dinner at an Oxford College <IMG alt=" " src="http://www.biotrinity.com/images/tri.gif">34 VCs and Investors already confirmed </TD></TR></TBODY></TABLE> For the first time, BioTrinity 2009 will also feature <A href="http://www.biotrinity.com/keynotes.html">plenaries and panel discussions</A> involving some of Oxford's most successful entrepreneurs Ian Nicholson, Bryan Morton, Anker Lundemose and Bruce Savage, as well as the entrpreneurs John Burt, David Knowles and Ken Powell drawn from across the UK who have returned nearly $500m of value to their investors.   35 corporate presentations will be made by companies selected from Oxford, London, Cambridge as well as Bristol, Southampton, Kent, Nottingham, Manchester and Newcastle, making BioTrinity a <A href="http://www.biotrinity.com/emerging_company_showcase.html">UK Biotechnology Showcase</A>.  The latest addition is Heptares Therapeutics, which just completed a �21m funding round. In yet another first, BioTrinity 2009 will feature live recording of interviews by <A href="http://www.pharmatelevision.com/">PharmaTV</A> adjacent to the main networking hub, so if you want to appear on the groundbreaking online TV channel for the biopharma industry, make sure you are in Oxford from April 2-3, 2009. BioTrinity unites the UK�s biotech industry, and provides an ideal platform to meet with pharma, investors and biotech companies in the most beautiful city in England, just 1 hours' drive from Heathrow International Airport. The updated programme for BioTrinity has been published online and can be <A href="http://www.biotrinity.com/">downloaded</A>. ........................................................................................... <H1 class=style6>Is your company missing from the list of companies attending BioTrinity 2009?</H1> <TABLE cellSpacing=0 cellPadding=0 width="100%" border=0> <TBODY> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    AstraZeneca</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Bristol Myers-Squibb</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Eli Lilly</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Genzyme</TD> <TD vAlign=top width=180 bgColor=#ffffff> GSK</TD> <TD vAlign=top width=180 bgColor=#ffffff> Merck</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    Novartis</TD> <TD vAlign=top width=180 bgColor=#bbdaef> (OSI) Pharmaceuticals</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Roche</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Shire Pharma</TD> <TD vAlign=top width=180 bgColor=#ffffff> Takeda</TD> <TD vAlign=top width=180 bgColor=#ffffff> Teva Pharma</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    Abingworth Mgmt</TD> <TD vAlign=top width=180 bgColor=#bbdaef> EUSA Pharma</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Atlas Venture</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Albion Ventures</TD> <TD vAlign=top width=180 bgColor=#ffffff> Andy Richards</TD> <TD vAlign=top width=180 bgColor=#ffffff> Avlar BioVentures</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    BSI SA</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Advent Venture Partners</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Canaccord Adams</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Excalibur Group</TD> <TD vAlign=top width=180 bgColor=#ffffff> ETV Capital</TD> <TD vAlign=top width=180 bgColor=#ffffff> Esperante Ventures</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    Edmond de Rothschld Invest</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Forbion Capital Partners</TD> <TD vAlign=top width=180 bgColor=#bbdaef> H2O Venture Partners</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Genzyme Ventures</TD> <TD vAlign=top width=180 bgColor=#ffffff> H2O Venture Partners</TD> <TD vAlign=top width=180 bgColor=#ffffff> Mercia Tech. Seed Fund</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    MPHVM</TD> <TD vAlign=top width=180 bgColor=#bbdaef> MVM Life Science </TD> <TD vAlign=top width=180 bgColor=#bbdaef> Nomura Code Securities</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Novo A/S</TD> <TD vAlign=top width=180 bgColor=#ffffff> Oxford Capital Partners</TD> <TD vAlign=top width=180 bgColor=#ffffff> Orion Healthcare Equity</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    Oxford Tech. Management</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Rainbow Seed Fund</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Piper Jaffray</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Rosetta Capital</TD> <TD vAlign=top width=180 bgColor=#ffffff> SPARK Ventures</TD> <TD vAlign=top width=180 bgColor=#ffffff> SR One</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    Takeda Research Investment </TD> <TD vAlign=top width=180 bgColor=#bbdaef> The Wellcome Trust</TD> <TD vAlign=top width=180 bgColor=#bbdaef> AbD Serotec</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    AdaptImmune</TD> <TD vAlign=top width=180 bgColor=#ffffff> Alchemy Healthcare</TD> <TD vAlign=top width=180 bgColor=#ffffff> Allergan</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    Almac Sciences</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Apitope</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Apex Healthcare Consulting</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Aptuit</TD> <TD vAlign=top width=180 bgColor=#ffffff> AS-Tec Chemicals</TD> <TD vAlign=top width=180 bgColor=#ffffff> ATP Bio</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    Avecia Biologics</TD> <TD vAlign=top width=180 bgColor=#bbdaef> BASi</TD> <TD vAlign=top width=180 bgColor=#bbdaef> BBSRC</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Bench International </TD> <TD vAlign=top width=180 bgColor=#ffffff> BigDNA </TD> <TD vAlign=top width=180 bgColor=#ffffff> BioCentrum (Poland)</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    BioCentury</TD> <TD vAlign=top width=180 bgColor=#bbdaef> BioConnection B.V.</TD> <TD vAlign=top width=180 bgColor=#bbdaef> BioDundee</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Bioedge Pharma</TD> <TD vAlign=top width=180 bgColor=#ffffff> Biomaterials & Tissue Engineering Centre</TD> <TD vAlign=top width=180 bgColor=#ffffff> BioPark</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    Biotech Personnel</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Biotecnol S.A.</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Biotica</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    BioUETIKON (Ireland)</TD> <TD vAlign=top width=180 bgColor=#ffffff> Bodium Consulting</TD> <TD vAlign=top width=180 bgColor=#ffffff> Bridgehead International</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    CABI</TD> <TD vAlign=top width=180 bgColor=#bbdaef> CML Europe</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Cancer Research UK</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Canaccord Adams</TD> <TD vAlign=top width=180 bgColor=#ffffff> Caprotec Bioanalytics GmbH</TD> <TD vAlign=top width=180 bgColor=#ffffff> Capsant</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    Carbogen Amcis AG </TD> <TD vAlign=top width=180 bgColor=#bbdaef> Catalent Pharma Solutions</TD> <TD vAlign=top width=180 bgColor=#bbdaef> CellCentric </TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Celleron Therapeutics</TD> <TD vAlign=top width=180 bgColor=#ffffff> Cellvax (France)</TD> <TD vAlign=top width=180 bgColor=#ffffff> Cellzome</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    Charles Russell LLP</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Chroma Therapeutics</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Circassia</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    CellCentric</TD> <TD vAlign=top width=180 bgColor=#ffffff> CLS Communication</TD> <TD vAlign=top width=180 bgColor=#ffffff> CMP Therapeutics</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    CMS Cameron McKenna</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Cognitive Drug Research</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Comm. Strat. Group, Inc</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Covance Laboratories</TD> <TD vAlign=top width=180 bgColor=#ffffff> CureVac (Germany)</TD> <TD vAlign=top width=180 bgColor=#ffffff> Cytox Group</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    D2M</TD> <TD vAlign=top width=180 bgColor=#bbdaef> D Young & Co. </TD> <TD vAlign=top width=180 bgColor=#bbdaef> De Facto Communications</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Debiopharm SA (Switz)</TD> <TD vAlign=top width=180 bgColor=#ffffff> Domainex</TD> <TD vAlign=top width=180 bgColor=#ffffff> Drug Discovery Today (media)</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    Drug Intelligence</TD> <TD vAlign=top width=180 bgColor=#bbdaef> EAPD Innovations</TD> <TD vAlign=top width=180 bgColor=#bbdaef> EBD Group, Inc.</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Eczacibasi Pharma (Turkey)</TD> <TD vAlign=top width=180 bgColor=#ffffff> Epistem</TD> <TD vAlign=top width=180 bgColor=#ffffff> e-Therapeutics plc</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    ETV Capital</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Eviva Pharma</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Evotec</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Eykona Technologies</TD> <TD vAlign=top width=180 bgColor=#ffffff> FOCUS Insurance</TD> <TD vAlign=top width=180 bgColor=#ffffff> FP7</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    Frank B Dehn</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Fry Heath Spence</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Fulcrum Pharma</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Fusion IP plc</TD> <TD vAlign=top width=180 bgColor=#ffffff> Genzyme</TD> <TD vAlign=top width=180 bgColor=#ffffff> Genzyme Ventures (US)</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    George James ltd</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Giles Insurance Brokers</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Glide Pharma</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    GlycoForm</TD> <TD vAlign=top width=180 bgColor=#ffffff> Glysure</TD> <TD vAlign=top width=180 bgColor=#ffffff> Haemostatix </TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    Health Protection Agency</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Heptares </TD> <TD vAlign=top width=180 bgColor=#bbdaef> High Commission of Canada</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Hybrid Systems </TD> <TD vAlign=top width=180 bgColor=#ffffff> Immune Targeting Systems</TD> <TD vAlign=top width=180 bgColor=#ffffff> Immunocore</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    IMS Health (media)</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Inhibox</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Inst. Pharma Innovation</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Interea International </TD> <TD vAlign=top width=180 bgColor=#ffffff> International LabMate</TD> <TD vAlign=top width=180 bgColor=#ffffff> Intertek</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    Isaac & Co</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Ithaka Life Sciences</TD> <TD vAlign=top width=180 bgColor=#bbdaef> J A Kemp & Co</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    James Cowper</TD> <TD vAlign=top width=180 bgColor=#ffffff> KWS BioTest</TD> <TD vAlign=top width=180 bgColor=#ffffff> Lab Support UK Ltd</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    Life Scientific (Ireland)</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Manches LLP</TD> <TD vAlign=top width=180 bgColor=#bbdaef> MEPC Milton Park</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Mewburn Ellis LLP</TD> <TD vAlign=top width=180 bgColor=#ffffff> Mitsui & Co Europe</TD> <TD vAlign=top width=180 bgColor=#ffffff> MorphoSys UK</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    MRC Harwell </TD> <TD vAlign=top width=180 bgColor=#bbdaef> Morrison & Foerster</TD> <TD vAlign=top width=180 bgColor=#bbdaef> M-Scan</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    NDA Analytics </TD> <TD vAlign=top width=180 bgColor=#ffffff> Netherlands FIA</TD> <TD vAlign=top width=180 bgColor=#ffffff> Niche Science & Technology</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    Nightingale Associates</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Novasep Synthesis</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Novolytics</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    O2H</TD> <TD vAlign=top width=180 bgColor=#ffffff> OBN</TD> <TD vAlign=top width=180 bgColor=#ffffff> OctoPlus N.V. (Netherlands)</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    OI Sciences</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Orthox</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Oxford BioMedica</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Oxford Expression Tech.</TD> <TD vAlign=top width=180 bgColor=#ffffff> Oxford Gene Technology</TD> <TD vAlign=top width=180 bgColor=#ffffff> Oxford Science Park</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    Oxford Transplant Centre</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Oxitec</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Particle Therapeutics</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Penn Pharma</TD> <TD vAlign=top width=180 bgColor=#ffffff> Pharmaceutical Profiles</TD> <TD vAlign=top width=180 bgColor=#ffffff> PharmaFor</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    PharmaLinks</TD> <TD vAlign=top width=180 bgColor=#bbdaef> PharmaTV</TD> <TD vAlign=top width=180 bgColor=#bbdaef> PharmaProjects</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    PharmaVentures</TD> <TD vAlign=top width=180 bgColor=#ffffff> Pharmidex</TD> <TD vAlign=top width=180 bgColor=#ffffff> Pharminox</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    Physiomics plc</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Pinnacle Associates</TD> <TD vAlign=top width=180 bgColor=#bbdaef> PiR Interims</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Plant Vaccines Limited</TD> <TD vAlign=top width=180 bgColor=#ffffff> Polytherics</TD> <TD vAlign=top width=180 bgColor=#ffffff> ProPharma Partners</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    Protherics, A BTG Company</TD> <TD vAlign=top width=180 bgColor=#bbdaef> PULSE Scientific</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Reed Scientific</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    RegenTec</TD> <TD vAlign=top width=180 bgColor=#ffffff> Regulatory Resources Group</TD> <TD vAlign=top width=180 bgColor=#ffffff> Riverbank IT Management</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    RSSL Pharma</TD> <TD vAlign=top width=180 bgColor=#bbdaef> RUSSLAN Clinical Research</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Ruston Poole International</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Saint Malo Agglomeration</TD> <TD vAlign=top width=180 bgColor=#ffffff> Saltigo</TD> <TD vAlign=top width=180 bgColor=#ffffff> SCRIP</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    SEHTA</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Selcia</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Simbec Research</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Solace Pharma</TD> <TD vAlign=top width=180 bgColor=#ffffff> Sochinaz / Bachem</TD> <TD vAlign=top width=180 bgColor=#ffffff> Solvias AG (Switzerland)</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    SP Industries</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Steve D Young & Co</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Summit plc</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    SynCo Bio Partners B.V.</TD> <TD vAlign=top width=180 bgColor=#ffffff> Syntagon (Sweden)</TD> <TD vAlign=top width=180 bgColor=#ffffff> Syntaxin</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    Synth-Isis</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Talentmark</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Technomark Life Sciences</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Tepnel</TD> <TD vAlign=top width=180 bgColor=#ffffff> Thermal Transfer</TD> <TD vAlign=top width=180 bgColor=#ffffff> Therabel Europe (Ireland)</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    ThermoFisher Scientific</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Thiakis (now part of Wyeth)</TD> <TD vAlign=top width=180 bgColor=#bbdaef> TNO Quality of Life </TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    TVLSN</TD> <TD vAlign=top width=180 bgColor=#ffffff> Ubichem Plc</TD> <TD vAlign=top width=180 bgColor=#ffffff> UK Trade and Investment</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    UniTech Pharma (Sweden)</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Universit� Libre de Bruxelles</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Univ. Manc. Incubtor Co.</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#ffffff>    Univ. of Manchester IP</TD> <TD vAlign=top width=180 bgColor=#ffffff> VirdisPharma</TD> <TD vAlign=top width=180 bgColor=#ffffff> Wragge & Co LLP</TD></TR> <TR> <TD vAlign=top width=180 bgColor=#bbdaef>    Isogenica</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Ipso Ventures</TD> <TD vAlign=top width=180 bgColor=#bbdaef> Piramal Healthcare</TD></TR></TBODY></TABLE> <A href="http://www.biotrinity.com/companies_attending.html">See who else is attending...</A> ........................................................................................... <H3 style="FONT-SIZE: small; COLOR: #020a27; FONT-FAMILY: Arial, Helvetica, sans-serif" align=left>What other people think: </H3> "My first time at a UK partnering conference was BioTrinity 2008, and I did a deal with an NZ pharma as a direct result". Allen Hakimi, Managing Director at Technomark Life Sciences "As a direct result of our focused partnering meetings we introduced proteros to potential clients at BioTrinity 2008 which we are pleased to report resulted in several new opportunities and one of which has developed into a substantial business relationship". Gordon J Woodrow, VP at Proteros biostructures GmbH "...I would like to congratulate you on an excellent meeting.." Tim Haines, Partner, Abingworth Management "...Congratulations on such a good event. I had a very productive day with lots of organized and impromptu meetings - a very worthwhile event for me." Dr Charles Potter, CEO, Glide Pharma <A href="http://www.biotrinity.com/testimonials.html">Read more testimonials...</A> <A href="http://www.partneringone.com/registration.php?id=5444f$b7CO2D0GXZGAw&regtype=12444f$b75XWW8TPtGCA"><IMG height=88 alt="Register online now! www.biotrinity.com" src="http://www.biotrinity.com/images/register_button.jpg" width=205 border=0></A> Register online now at <A href="http://www.biotrinity.com/">www.biotrinity.com</A> ............................................................................................ <H1 class=style6>Thanks to our Sponsors:</H1> <IMG src="http://www.biotrinity.com/2009/images/sponsors_4_biotrinity.jpg" align=center> ............................................................................................ <H5 style="PADDING-LEFT: 5px; COLOR: #020a27; FONT-FAMILY: Arial, Helvetica, sans-serif" align=center>BioTrinity is organised by OBN - Rapidly becoming the UK's leading biotech network</H5> <A href="http://www.oxfordshirebioscience.com"><IMG height=63 alt=OBN src="http://www.biotrinity.com/email/2008/sponsors/obn_100x63.gif" width=100 border=0></A>   </TD></TR> <TR></TR> <TR> <TD bgColor=#025273> � 2006-2009 <A style="COLOR: #fff" href="http://www.obn.org.uk/">OBN</A> Contact OBN to unsubscribe on 01865 594640 or <a HREF="mailto:info@obn.org.uk">info@obn.org.uk</a></A> </TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE>